PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsAbscess
MeSH D000038 - abscess
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D013492:Suppuration
0 Companies
0 Drugs
Success rate
D000038: 
Abscess
$
Success rate
D000039:Peritonsillar abscess
0 Companies
0 Drugs
Success rate
D001922:Brain abscess
0 Companies
0 Drugs
Success rate
D008169:Lung abscess
0 Companies
0 Drugs
Success rate
D010482:Periapical abscess
0 Companies
0 Drugs
Success rate
D010508:Periodontal abscess
0 Companies
0 Drugs
Success rate
D016659:Psoas abscess
0 Companies
0 Drugs
Success rate
D017703:Retropharyngeal abscess
0 Companies
0 Drugs
Success rate
D018784:Abdominal abscess
$
Success rate
D020802:Epidural abscess
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaMetronidazole Metronidazole  1984-11-06   
Metronidazole Vandazole 2024-09-22 2005-05-20   
PadagisMetronidazole Metronidazole  2019-07-02   
Taro PharmaceuticalMetronidazole Metronidazole  2006-07-18   
Glenmark PharmaceuticalsMetronidazole Metronidazole  2022-01-27   
Johnson & JohnsonMetronidazole Protostat  1983-03-02   
Lupin ResearchMetronidazole Metronidazole  2017-09-12   
Bausch Health CompaniesMetronidazole Metrogel  1992-08-17   
Metronidazole Noritate  1997-09-26   
PfizerMetronidazole Flagyl  1982-01-01   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/1
Phase 2
83%
5/6
Phase 3
32%
8/25
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Johnson & Johnson
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use